Cargando…

Analysis of macroautophagy related proteins in G2019S LRRK2 Parkinson’s disease brains with Lewy body pathology

LRRK2, the gene encoding the multidomain kinase Leucine-Rich Repeat Kinase 2 (LRRK2), has been linked to familial and sporadic forms of Parkinson’s disease (PD), as well as cancer, leprosy and Crohn’s disease, establishing it as a target for discovery therapeutics. LRRK2 has been associated with a r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mamais, Adamantios, Manzoni, Claudia, Nazish, Iqra, Arber, Charles, Sonustun, Berkiye, Wray, Selina, Warner, Thomas T., Cookson, Mark R., Lewis, Patrick A., Bandopadhyay, Rina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier/North-Holland Biomedical Press 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6361106/ https://www.ncbi.nlm.nih.gov/pubmed/30055128 http://dx.doi.org/10.1016/j.brainres.2018.07.023

Ejemplares similares

Differential LRRK2 signalling and gene expression in WT-LRRK2 and G2019S-LRRK2 mouse microglia treated with zymosan and MLi2
por: Nazish, Iqra, et al.
Publicado: (2023)

Inhibition of LRRK2 kinase activity stimulates macroautophagy()
por: Manzoni, Claudia, et al.
Publicado: (2013)

Divergent α-synuclein solubility and aggregation properties in G2019S LRRK2 Parkinson's disease brains with Lewy Body pathology compared to idiopathic cases()
por: Mamais, Adamantios, et al.
Publicado: (2013)

mTOR independent regulation of macroautophagy by Leucine Rich Repeat Kinase 2 via Beclin-1
por: Manzoni, Claudia, et al.
Publicado: (2016)

The LRRK2–macroautophagy axis and its relevance to Parkinson's disease
por: Manzoni, Claudia
Publicado: (2017)

Abrogation of LRRK2 dependent Rab10 phosphorylation with TLR4 activation and alterations in evoked cytokine release in immune cells
por: Nazish, Iqra, et al.
Publicado: (2021)

Arsenite Stress Down-regulates Phosphorylation and 14-3-3 Binding of Leucine-rich Repeat Kinase 2 (LRRK2), Promoting Self-association and Cellular Redistribution
por: Mamais, Adamantios, et al.
Publicado: (2014)

Preclinical modeling of chronic inhibition of the Parkinson’s disease associated kinase LRRK2 reveals altered function of the endolysosomal system in vivo
por: Kluss, Jillian H., et al.
Publicado: (2021)

Pathological Relevance of Post-Translationally Modified Alpha-Synuclein (pSer87, pSer129, nTyr39) in Idiopathic Parkinson’s Disease and Multiple System Atrophy
por: Sonustun, Berkiye, et al.
Publicado: (2022)

mTOR independent alteration in ULK1 Ser758 phosphorylation following chronic LRRK2 kinase inhibition
por: Manzoni, Claudia, et al.
Publicado: (2018)

Pathogenic Parkinson’s disease mutations across the functional domains of LRRK2 alter the autophagic/lysosomal response to starvation()
por: Manzoni, Claudia, et al.
Publicado: (2013)

Phosphorylation of 4E-BP1 in the Mammalian Brain Is Not Altered by LRRK2 Expression or Pathogenic Mutations
por: Trancikova, Alzbeta, et al.
Publicado: (2012)

Cellular processes associated with LRRK2 function and dysfunction
por: Wallings, Rebecca, et al.
Publicado: (2015)

GTP binding controls complex formation by the human ROCO protein MASL1
por: Dihanich, Sybille, et al.
Publicado: (2014)

Sequential screening nominates the Parkinson's disease associated kinase LRRK2 as a regulator of Clathrin-mediated endocytosis
por: Heaton, George R., et al.
Publicado: (2020)

Mutations in LRRK2 linked to Parkinson disease sequester Rab8a to damaged lysosomes and regulate transferrin-mediated iron uptake in microglia
por: Mamais, Adamantios, et al.
Publicado: (2021)

Detection of endogenous S1292 LRRK2 autophosphorylation in mouse tissue as a readout for kinase activity
por: Kluss, Jillian H., et al.
Publicado: (2018)

Correction: Mutations in LRRK2 linked to Parkinson disease sequester Rab8a to damaged lysosomes and regulate transferrin-mediated iron uptake in microglia
por: Mamais, Adamantios, et al.
Publicado: (2022)

Pathogenic LRRK2 Mutations Do Not Alter Gene Expression in Cell Model Systems or Human Brain Tissue
por: Devine, Michael J., et al.
Publicado: (2011)

LRRK2 in Parkinson's disease and dementia with Lewy bodies
por: Zhu, Xiongwei, et al.
Publicado: (2006)

Correction: Pathogenic LRRK2 Mutations Do Not Alter Gene Expression in Cell Model Systems or Human Brain Tissue
por: Devine, Michael J., et al.
Publicado: (2012)

The LRRK2 signalling system
por: Price, Alice, et al.
Publicado: (2018)

LRRK2 mediates tubulation and vesicle sorting from lysosomes
por: Bonet-Ponce, Luis, et al.
Publicado: (2020)

Perspective on the current state of the LRRK2 field
por: Taymans, Jean-Marc, et al.
Publicado: (2023)

The Parkinson’s Disease Protein LRRK2 Interacts with the GARP Complex to Promote Retrograde Transport to the trans-Golgi Network
por: Beilina, Alexandra, et al.
Publicado: (2020)

Phosphorylation of LRRK2 by casein kinase 1α regulates trans-Golgi clustering via differential interaction with ARHGEF7
por: Chia, Ruth, et al.
Publicado: (2014)

In silico comparative analysis of LRRK2 interactomes from brain, kidney and lung
por: Verma, Amrita, et al.
Publicado: (2021)

Functional interaction of Parkinson's disease-associated LRRK2 with members of the dynamin GTPase superfamily
por: Stafa, Klodjan, et al.
Publicado: (2014)

Dysregulation of glucose metabolism is an early event in sporadic Parkinson's disease()
por: Dunn, Laura, et al.
Publicado: (2014)

α-Synuclein impairs macroautophagy: implications for Parkinson’s disease
por: Winslow, Ashley R., et al.
Publicado: (2010)

Trafficking of the glutamate transporter is impaired in LRRK2-related Parkinson’s disease
por: Iovino, Ludovica, et al.
Publicado: (2022)

Proteomic analysis reveals co-ordinated alterations in protein synthesis and degradation pathways in LRRK2 knockout mice
por: Pellegrini, Laura, et al.
Publicado: (2018)

Fine-Mapping, Gene Expression and Splicing Analysis of the Disease Associated LRRK2 Locus
por: Trabzuni, Daniah, et al.
Publicado: (2013)

Unfolded Protein Response and Macroautophagy in Alzheimer’s, Parkinson’s and Prion Diseases
por: Milisav, Irina, et al.
Publicado: (2015)

Targeting Macroautophagy as a Therapeutic Opportunity to Treat Parkinson’s Disease
por: Sanchez-Mirasierra, Irene, et al.
Publicado: (2022)

Rare variants in LRRK1 and Parkinson's disease
por: Schulte, Eva C., et al.
Publicado: (2013)

Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson's disease?
por: Rudenko, Iakov N, et al.
Publicado: (2012)

Coding and Noncoding Variation in LRRK2 and Parkinson's Disease Risk
por: Lake, Julie, et al.
Publicado: (2021)

TDP-43 pathology in a patient carrying G2019S LRRK2 mutation and a novel p.Q124E MAPT()
por: Ling, Helen, et al.
Publicado: (2013)

Nonmotor Symptoms in LRRK2 G2019S Associated Parkinson’s Disease
por: Gaig, Carles, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_1vapersjnfs6ck1lh88omfgckm